Certificate in Non-Clinical Psychopharmacology
The Certificate is a 4-day residential course held bi-annually in Cambridge, the next meeting is scheduled for 4th - 8th March 2018.
The aim of the programme is to increase awareness of, and interest in, experimental psychopharmacology through the provision of a cluster of training modules which covered key aspects of research on animals and humans (as well as professional development in this field). The modules are of particular relevance to Home Office Licence holders as they provide essential continuing professional development for researchers in industrial and academic centres whose work involves experiments on animals.
The following topics were covered:
- Clinical Neuroscience
- Pharmacokinetics in Psychiatry
- The Molecular Biology of the Mind
- Statistics and Experimental Design
- Pre-clinical Behavioural Psychopharmacology
- Combining Neurobiology and Behaviour
- In vivo-Neuroimaging and electrophysiology in Psychopharmacology
In addition to taught sections, the residential course includes round-table debates, practical sessions team projects and a guest lecture.
Approved by the Royal Society of Biology for purposes of CPD, this event may be counted as 108 CPD credits.
Dr Paula Moran and Professor Hugh Marston
The cost for the whole 4 day residential course is £870 all inclusive.
The cost for the 4 day course WITHOUT accommodation is £570.
Any queries regarding payment or to request a payment plan please contact Lynne Harmer.
To be entitled to a refund, cancellations must be received, in writing, 30 days prior to the course date.
BAP is not responsible for problems beyond our control, such as adverse weather conditions and/or cancellation of public transport. No refunds will be given in these circumstances.
"As a new student to the UK, the course exposed me to the recent research and advances in psychopharmacology that are being driven by quality British researchers and clinicians."
– Alonzo Whyte, M.S. Neuroscience (Vanderbilt University), Studying for a PhD in attention regulation in rat models of schizophrenia (University of St Andrews)